Plain-English translation of NCT07028112 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study looks at people who received a stem cell transplant at least 10 years ago. Researchers want to understand whether iron that builds up in the body over time increases the risk of liver problems after transplant. The study will review medical records and do simple, non-invasive tests to measure liver health.
After a stem cell transplant, some patients develop iron overload—extra iron stored in their body—which can damage the liver. Doctors aren't yet sure how big a problem this is for long-term survivors or whether treating iron overload can prevent liver damage later on. This study aims to find answers.
You likely qualify if…
You likely don't qualify if…
You will participate during one of your routine annual check-up visits at Saint-Louis Hospital. During that visit, you'll have blood tests and a simple, painless imaging test called FibroScan or shear wave elastography to measure how stiff your liver is. Researchers will also review your transplant records and past medical history to see if iron buildup affected your liver health.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France
Enrollment target
~500 participants
Started
August 2025
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mathilde Ruggiu, MD
Assistance Publique - Hôpitaux de Paris
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.